Arkolith/Insider Trading/AXNX/Form 4

Noblett Karen

Chief Medical OfficerAxonics, Inc. (AXNX) · full profile →Form 4 · filed Dec 28, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$506K
Net Open-Market Flow
-$506K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 28, 2023Sell(S)7K$63.28$446K34K
Dec 26, 2023Sell(S)949$63.00$60K41K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-23-008578) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML